3D Bioprinting in Cancer Applications is an all-encompassing guide covering both fundamentals concerning biofabrication principles and intricate protocols for precise construction of biomimetric 3D systems supporting advanced cell culture development that faithfully recapitulates human disease hallmarks, with a special focus on cancer. This title fills the void left by existing publications overlooking essential aspects associated with combining multimodal medical imaging alongside precision cancer treatment options. In 12 chapters
3D Bioprinting in Cancer Applications leads the reader from an introduction to bioprinting technologies for cancer models, to models for immunotherapy and tumour-immune interaction, to biomimetrics 3D models to the applications of all these models in 3D bioprinted cancer models .
3D Bioprinting in Cancer Applications uniquely combines distinct modalities under a unified framework suitable not only for seasoned veterans but also newly minted trainees encountering these sophisticated practices for the first time.
- Gives comprehensive insights on the use of phytocompounds in the synthesis of eco-friendly nanoparticles for enhanced drug delivery in cancer applications
- Provides concise updates on fresh discoveries in 3D printed biotechnologies
- Includes high-resolution depictions to enhance accessibility while avoiding too many lengthy equations or calculations impeding quick absorption of fundamental ideas
- Contributed by distinguished investigators across multiple countries and different specialties critical for mastering 3D bioprinted models
Dr. Fahima Dilnawaz is a Women Scientist, Department of Science and Technology, in the laboratory of Nanomedicine at Institute of Life Sciences, Bhubaneswar, Odisha, India. She received doctorate in Botany from Utkal University, ITC fellowship from Hungarian Academy of Sciences, and a Post-Doctoral Fellowship from Department of Biotechnology. Being a dynamic researcher, she has h-index of 16, more than 30 scientific paper, review
articles, 15 book chapters in reputed journals as well as publishing house. Her expertise has been much-admired for which she was invited to deliver talks in various scientific gathering in India as well as abroad. She has co-authored book “Remedial Biology”. To her credit, she has co-authored two patents, which has acclaimed approval of USA, Europe, Australian, other one India. The patented technology was commercialized for” magnetic cell separation kit (QuikSort TM)”. She is serving as reviewer for various nanomedicinal journals, and associated editorial board member
Dr. Tripti Sharma currently serves as Associate Professor for the Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Siksha ‘O’Anusandhan (Deemed to be University), Bhubaneswar 751003, Odisha, India. She has 17 years of teaching experience in Pharmaceutical Chemistry at undergraduate and post graduate levels. She has 14 years of research experience in computational drug design, drug development. During this period, she has been involved in teaching and research. She is a life member of the Association of Pharmaceutical Teachers of India (APTI), Orissa Chemical Society. To her credit, she has more than 40 publications and 6 book chapters. She is serving as a reviewer in various national/international Journals as well.
Dr. Sahoo is a scientist at the Institute of Life Sciences in Bhubaneswar, India, since 2005. He earned his Ph.D. in 1999 from the University of Delhi in Delhi. From 1999 to 2001, he was a JSPS Postdoctoral Fellow at the School of Medicine, Kumamoto University, Kumamoto, Japan. This was followed by a four-year postdoctoral fellowship at the Nebraska Medical Centre in Omaha, Nebraska, USA, which included a two-year American Heart Association fellowship. Over 100 peer-reviewed research papers, including review articles and book chapters, have been published in high-quality scientific journals in this field. He is a specialist in nanotechnology-based medication delivery systems, primarily in the field of cancer. Dr. Sahoo was also named one of the top 2% of scientists in the world in the fields of Pharmacology and Toxicology in research conducted by the prestigious Stanford University in the United States and based on Standardised Indicators databases
Dr. Shanti Bhusan Senapati works as a scientist at the Institute of Life Sciences in
Bhubaneswar, India. In 1997, he received his B.V.Sc. & A.H. degree from O.U.A.T. He received his doctorate from the University of Nebraska Medical Centre in 2010. He received the Harris Prize in Cancer Research from UNMC in Nebraska, USA, in 2010, a Postdoctoral Fellowship in Pelotonia at Ohio State University's Comprehensive Cancer Centre in Columbus, Ohio, USA, in 2011, a Ramalingaswami fellowship from the Department of Biotechnology in India in 2012, a Predoctoral Students Travel prize to attend the AACR
meeting in 2009 (Denver, USA), and a Student merit scholarship from B.V.Sc, O.U.A.T
His group is actively engaged in studying various aspects of tumour microenvironment and interested in understanding and treating inflammation-mediated processes in prostate and pancreatic cancer
